首页> 外国专利> Pharmaceutical compositions containing a sinus node If current inhibitor i.e. ivabradine and an angiotensin-converting enzyme inhibitor i.e. perindopril for treating arterial hypertension

Pharmaceutical compositions containing a sinus node If current inhibitor i.e. ivabradine and an angiotensin-converting enzyme inhibitor i.e. perindopril for treating arterial hypertension

机译:包含窦性结节的If组合物,例如电流抑制剂伊伐布雷定和血管紧张素转化酶抑制剂即培哚普利,用于治疗高血压

摘要

Disclosed is a pharmaceutical composition comprising a selective and specific sinus node If current inhibitor which is ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, or one of its hydrates, crystalline forms or addition salts with a pharmaceutically acceptable acid and an agent that inhibits angiotensin-converting enzyme (ACE-inhibitor). The preferred selective and specific sinus node If current inhibitor is ivabradine hydrochloride or one of its hydrates or crystalline forms and the preferred ACE-inhibitor is perindopril. These pharmaceutical compositions are suitable for the treatment of arterial hypertension.
机译:公开了一种药物组合物,其包含选择性和特异性窦房结If电流抑制剂伊伐布雷定或3- {3-[{[((7S)-3,4-二甲氧基双环[4.2.0]] octa-1,3,5-三烯-7基]甲基}(甲基)氨基]丙基} -7,8-二甲氧基-1,3,4,5-四氢-2H-3-苯并ze庚因-2-一或其水合物,晶体形式或加成形式与药学上可接受的酸和抑制血管紧张素转化酶的药物(ACE抑制剂)形成盐。如果目前的抑制剂是盐酸伊伐布雷定或其水合物或晶体形式之一,并且优选的ACE抑制剂是培哚普利,则是首选的选择性和特异性窦房结。这些药物组合物适合于治疗高血压。

著录项

  • 公开/公告号NZ552221A

    专利类型

  • 公开/公告日2008-05-30

    原文格式PDF

  • 申请/专利权人 LES LABORATOIRES SERVIER;

    申请/专利号NZ20060552221

  • 发明设计人 BENATAR VIDAL;LEREBOURS-PIGEONNIERE GUY;

    申请日2006-12-20

  • 分类号C07D223/16;A61K31/55;A61K31/4184;A61P43/00;A61K45/06;A61K31/4422;A61P9/10;

  • 国家 NZ

  • 入库时间 2022-08-21 20:06:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号